Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3399 of 6351
-
Breath test could revolutionize asthma diagnosis
Diagnosis CompletedAsthma is caused by or worsened by different things in different people. It is because of these differences that not all people with asthma respond the same to all treatments and medicines. If the investigators can better identify the changes in the airways or breathing pipes in …
Early phase 1 • Sponsor: James Reynolds • Aim: Diagnosis
Last updated Jun 27, 2026 12:36 UTC
-
Less invasive drainage may match surgery for abscess treatment
Disease control Completed"Tubo-ovarian abscess (TOA) include pyosalpinx, ovarian abscess, tubo-ovarian abscess and Douglas abscess. The only randomized study evaluating TOA treatment reported a higher cure rate (90 versus 65%) when antibiotic therapy is associated with abscess evacuation. TOA evacuation…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Asthma relief in a chew? plant stanols put to the test
Symptom relief Recruiting nowPlant stanols are known to lower low-density lipoprotein cholesterol. However, studies have suggested that these compounds also influence the immune system. Asthmatic responses are predominantly T helper (Th)2 cell dependent, while plant stanols were previously found to activate …
Sponsor: Maastricht University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New drug cocktail targets Hard-to-Treat ovarian and endometrial cancers
Disease control CompletedThis phase Ib trial studies the best dose and side effects of niraparib and copanlisib in treating patients with endometrial, ovarian, primary peritoneal, or fallopian tube cancer that has come back. Niraparib and copanlisib may stop the growth of tumor cells by blocking some of …
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Hidden scar breast reconstruction: endoscopic technique spares muscle
Disease control CompletedImplant-based reconstruction is currently the most common choice for mastectomy reconstruction. Whatever the choice of mastectomy incision, a scar remains on or near the breast volume. Current techniques involve partial or total coverage of the implant with the pectoralis major m…
Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Brain zaps for OCD: new study targets blood flow
Symptom relief CompletedThis study will focus on the use of repetitive Transcranial Magnetic Stimulation (rTMS) as a treatment of Obsessive Compulsive Disorder (OCD), which is a common illness that impairs quality of life and that can be hard to treat. To precisely analyze the effects of rTMS on OCD, t…
Sponsor: Hospital Center Guillaume Régnier • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Online program eases belly pain in kids with pancreatitis
Symptom relief CompletedAbdominal pain is common in children with chronic and acute recurring pancreatitis (CP, ARP), and as they continue into adulthood, the disease progresses with increased pain and greater exposure to opioids. Despite the relevancy of early pain self-management for childhood pancrea…
Sponsor: Seattle Children's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Walnuts vs. prostate cancer: a nutty new hope?
Disease control Recruiting nowThis is a randomized control trial testing the effect of walnut supplementation on prostate cancer progression in 50 men with biopsy confirmed prostate cancer and planning to undergo RP. Patients consented to the study will be randomly assigned to either continue their usual diet…
Phase 2 • Sponsor: Stephen Freedland • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New study aims to end false food allergy diagnoses in eczema patients
Knowledge-focused Recruiting nowBackground: Atopic dermatitis (AD), also called eczema, makes skin dry, red, and itchy. People with AD are more likely to get a food allergy than people without AD. But some food allergy tests are not always accurate in people with AD. Researchers want to study if people are tru…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
New speech therapy shows promise for kids with apraxia
Symptom relief CompletedChildhood apraxia of speech (CAS) is a pediatric motor speech disorder that impairs the planning of movements needed for intelligible speech. Children with CAS often show little or slow progress in standard speech therapy. This research is a Phase 1 study that tests initial effic…
Phase 1 • Sponsor: Temple University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New drug combo shows promise in advanced breast cancer trial
Disease control OngoingThis is a multi-institutional pilot trial for patients with advanced breast cancer. The trial is designed to assess the safety and tolerability of induction talazoparib followed by combination of talazoparib and avelumab. As an exploratory endpoint, the study team will evaluate t…
Phase 1/2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New pill combo aims to tame Hard-to-Treat cancers
Disease control OngoingThis is a phase 1 study of the combination of cedazuridine with decitabine in patients with solid tumors. At least 6 patients will be enrolled per treatment level to assess optimal hypomethylation and toxicity (up to 35 patients total).
Phase 1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Itch relief showdown: which drug stops water-induced agony?
Symptom relief CompletedPhase 3, randomized prospective study, double blind-double placebo, testing oral therapies APREPITANT versus HYDROXYZINE in patients followed for myeloproliferative neoplasms and suffering of persistent aquagenic pruritus.
Phase 3 • Sponsor: University Hospital, Brest • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Study probes whether exercise and meditation shield aging brains from stress damage
Knowledge-focused By invitation onlyThis project capitalizes on a natural experiment imposed by the COVID-19 pandemic in conjunction with an extensive set of cognitive, emotional, biological, and neuroimaging variables already collected at multiple time points in older adults participating in a clinical trial of ex…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Old arthritis drug shows promise against aggressive breast cancer
Disease control CompletedTriple negative breast cancer (TNBC) represents about 15% of breast cancers and is characterized by the lack of expression of estrogen receptor (ER), progesterone receptor (PR), and HER-2 non-amplification. Women with TNBC tend to be younger, African American, and BRCA-1 germline…
Phase 1/2 • Sponsor: Joseph Sparano • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Talking therapy for NICU parents may boost premature babies' futures
Disease control Recruiting nowThis study is being done to see if outcomes for both a premature infant's parents and the infant born prematurely who have spent time in the neonatal intensive care unit (NICU) can be improved through parent cognitive behavioral therapy (CBT) sessions.
Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Fish oil supplements show promise for stubborn leg ulcers
Symptom relief CompletedThe purpose of this study is to test the efficacy of an oral, nutrient intervention containing the bioactive components of fish oil to promote healing of chronic venous leg ulcers (CVLUs) by reducing the chronic inflammation at wound sites that prevents healing progression. If th…
Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Exercise and nutrition may ease chemo nerve damage
Symptom relief CompletedChemotherapy-induced peripheral neuropathy (CIPN) is a highly prevalent and severe side-effect of taxane chemotherapy, often used to treat breast cancer. Unfortunately there are very limited treatments for CIPN. This is a phase II randomized controlled trial to test the prelimina…
Phase 2 • Sponsor: University of Rochester • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Smart pump learns your workout routine to stop dangerous sugar drops
Disease control CompletedThis is a randomized crossover trial with 1:1 randomization to the admission sequence of using the Control AP system (rMPC - Naïve Model Predictive Control) vs. Experimental AP system (EnMPC - Ensemble Model Predictive Control) over approximately 4 months. Eligible participants w…
Sponsor: Marc Breton • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New device aims to calm stress and sleeplessness without drugs
Symptom relief Recruiting nowThe purpose of this study is to evaluate the use of Cereset Research to improve autonomic function in participants with symptoms of stress, anxiety, or insomnia.
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC